1. Cellular immunity to viral antigens limits E-1 deleted adenoviruses for gene therapy;Yang,1994
2. Immune responses to viral antigens versus transgene product in the elimination of recombinant adenovirus-infected hepatocytes in vivo;Yang;Gene Ther,1996
3. Foetal and neonatal immunology;Solomon,1971
4. Surfactant protein-B deficiency;Nogee;Chest,1997
5. Ornithine transcarbamylase deficiency: A model for gene therapy;Morsy;Adv Exp Med Biol,1994